Preserved prenatal lung growth assessed by fetal MRI in the omicron-dominated phase of the SARS-CoV-2 pandemic - Summary - MDSpire

Preserved prenatal lung growth assessed by fetal MRI in the omicron-dominated phase of the SARS-CoV-2 pandemic

  • By

  • Gloria Biechele

  • Vanessa Koliogiannis

  • Philippe Rennollet

  • Tobias Prester

  • Enrico Schulz

  • Thomas Kolben

  • Magdalena Jegen

  • Christoph Hübener

  • Uwe Hasbargen

  • Andreas Flemmer

  • Olaf Dietrich

  • Tanja Burkard

  • Regina Schinner

  • Julien Dinkel

  • Maximilian Muenchhoff

  • Susan Hintz

  • Maria Delius

  • Sven Mahner

  • Jens Ricke

  • Anne Hilgendorff

  • Sophia Stoecklein

  • August 30, 2024

  • 0 min

Share

Objective:

To investigate the effects of SARS-CoV-2 infection during pregnancy on fetal lung volume in the omicron-dominated phase of the pandemic, highlighting its significance compared to earlier variants.

Key Findings:
  • Fetal lung volumes in the SARS-CoV-2 positive group were comparable to age-adjusted reference values and non-COVID controls, suggesting that hybrid immunity may have contributed to improved fetal outcomes.
Interpretation:

The study suggests that mild SARS-CoV-2 infection during the omicron phase does not adversely affect fetal lung growth, contrasting with findings from earlier pandemic phases.

Limitations:
  • Small sample size of the study group and potential biases related to participant selection.
Conclusion:

Mild SARS-CoV-2 infection during the omicron phase appears to preserve fetal lung growth, indicating potential improvements in pregnancy outcomes compared to earlier variants, warranting further research.

Original Source(s)

Preserved prenatal lung growth assessed by fetal MRI in the omicron-dominated phase of the SARS-CoV-2 pandemic

  • by Gloria Biechele, Vanessa Koliogiannis, Philippe Rennollet, Tobias Prester, Enrico Schulz, Thomas Kolben, Magdalena Jegen, Christoph Hübener, Uwe Hasbargen, Andreas Flemmer, Olaf Dietrich, Tanja Burkard, Regina Schinner, Julien Dinkel, Maximilian Muenchhoff, Susan Hintz, Maria Delius, Sven Mahner, Jens Ricke, Anne Hilgendorff, Sophia Stoecklein

  • August 30, 2024

Related Content

The Care Continuum of Patients With Influenza in the Post–COVID-19 Era: A Position Paper

31 Live Births Reported Following Uterus Transplant

Single-center series details maternal, obstetric, and neonatal outcomes among recipients with uterine-factor infertility

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.